Desferrioxamine-related ocular toxicity: A case report
A 29-year-old lady receiving repeated blood transfusions for β thalassemia since childhood, presented with rapidly deteriorating symptoms of night blindness and peripheral visual field loss. She was recently commenced on high-dose intravenous desferrioxamine for reducing the systemic iron overload....
Main Authors: | Simon, Sumu, Athanasiov, Paul A, Jain, Rajeev, Raymond, Grant, Gilhotra, Jagjit S |
---|---|
Format: | Online |
Language: | English |
Published: |
Medknow Publications & Media Pvt Ltd
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442469/ |
Similar Items
-
Cervical Carcinoma Manifesting as Progressive Bilateral Visual Loss
by: Shibeeb, O'Sam, et al.
Published: (2014) -
Hip-implant related chorio-retinal cobalt toxicity
by: Ng, Soo K, et al.
Published: (2013) -
Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
by: Pepe, Alessia, et al.
Published: (2011) -
Desferrioxamine treatment in thalassaemia: a cost utility analysis
by: Husna Zayadi
Published: (2007) -
Desferrioxamine Reduces Oxidative Stress in the Lung Contusion
by: Basaran, Umit Nusret, et al.
Published: (2013)